COMMUNIQUÉS West-GlobeNewswire

Orasure Technologies Appoints James a. Datin to Its Board of Directors
14/08/2019
BETHLEHEM, PA, Aug. 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of James A. Datin, [...]
ViroGates appoints Mark Christian Hvidberg da Silva as its new CFO
14/08/2019
Company announcement no. 9-2019 Birkerød, 14 August 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for acute care departments in hospitals, today announces that Mark [...]
Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
14/08/2019
Supports Epigenetics Symposium During ESC Congress CALGARY, Alberta, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announces today that it will present at ESC Congress [...]
Sharps Compliance Announces Fourth Quarter Fiscal 2019 Conference Call and Webcast
14/08/2019
HOUSTON, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its fourth quarter 2019 results for the period ended June 30, 2019, before the opening of the [...]
Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431
14/08/2019
Study Represents the Third and Final Stage of CRV431’s Streamlined Early Clinical Program EDISON, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused [...]
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
14/08/2019
Program aims to be first disease-modifying treatment for this serious neurogenetic disorder Ultragenyx receives an exclusive option to acquire GeneTx NOVATO, Calif. and DOWNERS GROVE, Ill., Aug. 14, 2019 (GLOBE NEWSWIRE [...]
Golden Leaf Holdings Releases New Investment Presentation
14/08/2019
TORONTO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues
14/08/2019
SCOTTSDALE, Ariz., Aug. 14, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ) today announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Company’s novel [...]
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
14/08/2019
Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung [...]
Novan Advances Women’s Health Business Unit with Non-Dilutive Funding
14/08/2019
Company has received NIH federal grant of approximately $223,000 Anticipates additional federal grant of approximately $1.0 million Women’s health initiative to focus on potential HPV related onco-virus therapeutics [...]
Replimune Reports First Fiscal Quarter Financial Results and Provides Corporate Update
14/08/2019
RP1: Initial Data from Phase 1 part of Phase 1/2 clinical trial alone and in combination with nivolumab expected to be presented in the fourth calendar quarter of 2019 RP1: Enrollment is ongoing in the Phase 2 part of [...]
Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
14/08/2019
First patient dosed is a metastatic non-small cell lung cancer patient with a KRAS G12C mutation EMERYVILLE, Calif., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage [...]
Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
14/08/2019
Fast Track designation by the U.S. Food and Drug Administration (FDA) facilitates the development and expedites the review of new medicines like nomacopan that treat serious unmet medical needs and in Akari’s case, [...]
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
14/08/2019
Achieved 100% Patient Randomization in both TRILOGY trials 68% of randomized patients have completed the studies On track to report topline results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020 Fully [...]
Progyny Ranks #59 on the 2019 Inc. 5000
14/08/2019
The 38th annual list curates America’s fastest-growing private companies NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Progyny, a leading fertility benefits management company, today announced that it was named #59 on Inc [...]
aTyr Pharma Announces Second Quarter 2019 Results and Provides Corporate Update
14/08/2019
aTyr to report interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients in Q4 2019 Company to host conference call and webcast today, August 14, at 5:00pm EDT SAN [...]
BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019
14/08/2019
JERUSALEM and HACKENSACK, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today [...]
Aleafia Health Reports Record Revenue in Q2 2019, 159% Q/Q Revenue Increase
14/08/2019
Q/Q sale of cannabis revenues increase 377% Q/Q gross profit increases to $2.9M from -$0.1M in previous quarter Q/Q expenses decrease 41% Adjusted EBITDA improves to loss of $2.7 million Strong balance sheet with $58M [...]
resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update
14/08/2019
– Quarter highlighted by initiation and early completion of enrollment of Phase 3 PROTECTOR 1 trial; topline data expected by early first quarter of 2020 – BOSTON, Aug. 14, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ( [...]

Pages